1. Home
  2. NMTC vs NEPH Comparison

NMTC vs NEPH Comparison

Compare NMTC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMTC
  • NEPH
  • Stock Information
  • Founded
  • NMTC 2009
  • NEPH 1997
  • Country
  • NMTC United States
  • NEPH United States
  • Employees
  • NMTC N/A
  • NEPH N/A
  • Industry
  • NMTC Medical/Dental Instruments
  • NEPH Medical/Dental Instruments
  • Sector
  • NMTC Health Care
  • NEPH Health Care
  • Exchange
  • NMTC Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • NMTC 33.8M
  • NEPH 36.1M
  • IPO Year
  • NMTC N/A
  • NEPH 2004
  • Fundamental
  • Price
  • NMTC $0.72
  • NEPH $3.76
  • Analyst Decision
  • NMTC Strong Buy
  • NEPH Buy
  • Analyst Count
  • NMTC 1
  • NEPH 1
  • Target Price
  • NMTC $1.45
  • NEPH $5.00
  • AVG Volume (30 Days)
  • NMTC 180.3K
  • NEPH 69.7K
  • Earning Date
  • NMTC 08-13-2025
  • NEPH 08-07-2025
  • Dividend Yield
  • NMTC N/A
  • NEPH N/A
  • EPS Growth
  • NMTC N/A
  • NEPH N/A
  • EPS
  • NMTC N/A
  • NEPH 0.08
  • Revenue
  • NMTC $5,758,777.00
  • NEPH $15,517,000.00
  • Revenue This Year
  • NMTC $141.04
  • NEPH $17.06
  • Revenue Next Year
  • NMTC $38.86
  • NEPH $12.20
  • P/E Ratio
  • NMTC N/A
  • NEPH $48.73
  • Revenue Growth
  • NMTC 54.53
  • NEPH 10.34
  • 52 Week Low
  • NMTC $0.40
  • NEPH $1.36
  • 52 Week High
  • NMTC $1.39
  • NEPH $5.00
  • Technical
  • Relative Strength Index (RSI)
  • NMTC 63.09
  • NEPH 55.35
  • Support Level
  • NMTC $0.68
  • NEPH $3.83
  • Resistance Level
  • NMTC $0.77
  • NEPH $4.25
  • Average True Range (ATR)
  • NMTC 0.05
  • NEPH 0.40
  • MACD
  • NMTC 0.01
  • NEPH -0.08
  • Stochastic Oscillator
  • NMTC 73.64
  • NEPH 38.77

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: